1. The nucleotide receptor P2Y13 is a key regulator of hepatic High-Density Lipoprotein (HDL) endocytosis.
- Author
-
Jacquet, S., Malaval, C., Martinez, L. O., Sak, K., Rolland, C., Perez, C., Nauze, M., Champagne, E., Tercé, F., Gachet, C., Perret, B., Collet, X., Boeynaems, J.-M., and Barbaras, R.
- Subjects
LIVER cells ,ENDOCYTOSIS ,ABSORPTION (Physiology) ,CELL physiology ,CELL membranes ,ADENOSINE triphosphatase ,PHYSIOLOGICAL control systems ,ISOPENTENOIDS ,LOW-cholesterol diet ,NUCLEIC acids - Abstract
Cell surface receptors for high-density lipoprotein (HDL) on hepatocytes are major partners in the regulation of cholesterol homeostasis. We recently identified a cell surface ATP synthase as a high-affinity receptor for HDL apolipoprotein A-I (apoA-I) on human hepatocytes. Stimulation of this ectopic ATP synthase by apoA-I triggered a low-affinity-receptor-dependent HDL endocytosis by a mechanism strictly related to the generation of ADP. This suggests that nucleotide G-protein- coupled receptors of the P2Y family are molecular components in this pathway. Only P2Y
1 and P2Y13 are present on the membrane of hepatocytes. Using both a pharmacological approach and small interference RNA, we identified P2Y13 as the main partner in hepatic HDL endocytosis, in cultured cells as well as in situ in perfused mouse livers. We also found a new important action of the antithrombotic agent AR-C69931MX as a strong activator of P2Y13 -mediated HDL endocytosis. [ABSTRACT FROM AUTHOR]- Published
- 2005
- Full Text
- View/download PDF